Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
8.19
+0.23 (2.89%)
At close: Aug 5, 2025, 4:00 PM
8.18
-0.01 (-0.12%)
After-hours: Aug 5, 2025, 4:10 PM EDT
Theseus Pharmaceuticals Employees
Amylyx Pharmaceuticals had 123 employees as of December 31, 2024. The number of employees decreased by 261 or -67.97% compared to the previous year.
Employees
123
Change (1Y)
-261
Growth (1Y)
-67.97%
Revenue / Employee
n/a
Profits / Employee
-$1,779,325
Market Cap
730.07M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 123 | -261 | -67.97% |
Dec 31, 2023 | 384 | 122 | 46.56% |
Dec 31, 2022 | 262 | 57 | 27.80% |
Dec 31, 2021 | 205 | 171 | 502.94% |
Dec 31, 2020 | 34 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AMLX News
- 5 days ago - Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 15 days ago - Amylyx Pharmaceuticals: A High-Risk Pipeline With Strong Upside Potential - Seeking Alpha
- 22 days ago - Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery - Benzinga
- 23 days ago - Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025 - Business Wire
- 4 weeks ago - Amylyx Pharmaceuticals to Host Event to Discuss Post-bariatric Hypoglycemia and Avexitide at ENDO 2025 - Business Wire
- 6 weeks ago - Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market - Benzinga
- 7 weeks ago - Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation - Accesswire